Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 2
1997 2
1999 2
2000 1
2001 1
2002 1
2004 1
2005 2
2006 1
2008 2
2009 2
2010 1
2011 3
2012 4
2013 3
2014 1
2016 2
2017 2
2018 2
2019 5
2020 4
2021 2
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Anti-V1/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controller.
Molinos-Albert LM, Baquero E, Bouvin-Pley M, Lorin V, Charre C, Planchais C, Dimitrov JD, Monceaux V, Vos M; ANRS VISCONTI Study Group; Hocqueloux L, Berger JL, Seaman MS, Braibant M, Avettand-Fenoël V, Sáez-Cirión A, Mouquet H. Molinos-Albert LM, et al. Among authors: braibant m. Cell Host Microbe. 2023 Aug 9;31(8):1275-1287.e8. doi: 10.1016/j.chom.2023.06.006. Epub 2023 Jul 10. Cell Host Microbe. 2023. PMID: 37433296 Free article.
HIV-1 antibodies in prevention of transmission.
Barin F, Braibant M. Barin F, et al. Among authors: braibant m. Curr Opin HIV AIDS. 2019 Jul;14(4):273-278. doi: 10.1097/COH.0000000000000553. Curr Opin HIV AIDS. 2019. PMID: 30973417 Review.
Epitope convergence of broadly HIV-1 neutralizing IgA and IgG antibody lineages in a viremic controller.
Lorin V, Fernández I, Masse-Ranson G, Bouvin-Pley M, Molinos-Albert LM, Planchais C, Hieu T, Péhau-Arnaudet G, Hrebík D, Girelli-Zubani G, Fiquet O, Guivel-Benhassine F, Sanders RW, Walker BD, Schwartz O, Scheid JF, Dimitrov JD, Plevka P, Braibant M, Seaman MS, Bontems F, Di Santo JP, Rey FA, Mouquet H. Lorin V, et al. Among authors: braibant m. J Exp Med. 2022 Mar 7;219(3):e20212045. doi: 10.1084/jem.20212045. Epub 2022 Mar 1. J Exp Med. 2022. PMID: 35230385 Free PMC article.
Impact of HIV-1 Diversity on Its Sensitivity to Neutralization.
Stefic K, Bouvin-Pley M, Braibant M, Barin F. Stefic K, et al. Among authors: braibant m. Vaccines (Basel). 2019 Jul 25;7(3):74. doi: 10.3390/vaccines7030074. Vaccines (Basel). 2019. PMID: 31349655 Free PMC article. Review.
Antimycobacterial activity of synthetic pamamycins.
Lefèvre P, Peirs P, Braibant M, Fauville-Dufaux M, Vanhoof R, Huygen K, Wang XM, Pogell B, Wang Y, Fischer P, Metz P, Content J. Lefèvre P, et al. Among authors: braibant m. J Antimicrob Chemother. 2004 Oct;54(4):824-7. doi: 10.1093/jac/dkh402. Epub 2004 Aug 18. J Antimicrob Chemother. 2004. PMID: 15317744
V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1.
Morgand M, Bouvin-Pley M, Plantier JC, Moreau A, Alessandri E, Simon F, Pace CS, Pancera M, Ho DD, Poignard P, Bjorkman PJ, Mouquet H, Nussenzweig MC, Kwong PD, Baty D, Chames P, Braibant M, Barin F. Morgand M, et al. Among authors: braibant m. J Acquir Immune Defic Syndr. 2016 Mar 1;71(3):237-45. doi: 10.1097/QAI.0000000000000854. J Acquir Immune Defic Syndr. 2016. PMID: 26413851 Free PMC article.
48 results